

Bloomberg Talks
Bloomberg
Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.
Episodes
Mentioned books

6 snips
Dec 12, 2024 • 8min
Carlyle's Mark Jenkins Talks $5.7B Capital Raise, Credit Market
Mark Jenkins, head of global credit at Carlyle Investment Management, shares insights on their impressive $5.7 billion capital raise for a flagship credit fund. He discusses the benefits of targeting underbanked businesses and the shifting landscape driven by changes in the banking sector. Jenkins highlights new opportunities in private investment markets, particularly asset-backed securities. He explains how private and public credit markets can complement each other while outlining a positive investment outlook going into 2025.

Dec 12, 2024 • 7min
Goldman's David Kostin Talks Market Outlook, Investment Strategy
David Kostin, Chief US equity strategist at Goldman Sachs, shares his expert insights on M&A activity and the S&P 500. He discusses the anticipated easing cycle by the Federal Reserve and its implications for stock prices. Kostin emphasizes investing in small and mid-sized businesses, targeting acquisition-ready companies for high risk-adjusted returns. He also explores the strategic focus on stocks with merger potential ahead of regulatory changes in 2025, highlighting the importance of diversification in a volatile market.

6 snips
Dec 12, 2024 • 8min
BofA President of Retail Banking Holly O'Neill Talks Consumer Spending
Holly O'Neill, President of Retail Banking at Bank of America, provides keen insights into consumer behavior as outlined in the latest consumer checkpoint report. She reveals strong household spending growth across all income levels, highlighting lower-income groups' resilience. The discussion also covers shifting trends towards discount stores and increased service and travel spending, alongside the influence of social media on purchasing. O'Neill emphasizes that consumers are more prepared to spend, even as they adapt their habits post-pandemic.

4 snips
Dec 11, 2024 • 12min
Interactive Brokers Chair Thomas Peterffy Talks Trump, M&A & Crypto
Thomas Peterffy, Chairman of Interactive Brokers, is a key financial wizard. He shares his views on the possible effects of a second Trump presidency, emphasizing deregulation and free market values. Peterffy weighs in on the optimistic stock market trends versus the hurdles in mergers and acquisitions. He expresses caution about cryptocurrencies, highlighting their speculative nature and market risks. Additionally, he advises investors on managing exposure to Bitcoin amid potential downturns. Dive into the fascinating world of finance with his insights!

6 snips
Dec 11, 2024 • 9min
Blue Owl Co-CEO Marc Lipschultz Talks Private Markets; Interest Rates
Marc Lipschultz, Co-CEO of Blue Owl Capital, dives into the evolving landscape of private markets. He emphasizes the critical role these markets will play in the future, particularly amid rising competition and sustained high interest rates. Lipschultz discusses the implications of recent acquisitions and the shift of major firms like BlackRock towards alternative credit. He highlights potential growth areas in direct lending and digital infrastructure while addressing the impact of inflation on the economy, showcasing a blend of caution and optimism.

Dec 11, 2024 • 17min
US Treasury Secretary Janet Yellen Talks Tariffs, Russian Sanctions
Janet Yellen, the US Treasury Secretary with a vast background in economics, discusses vital issues like broad-based tariffs and their potential impact on international trade. She highlights the significance of sanctions on Russia, particularly concerning oil exports and their military powers. Yellen also details the $20 billion aid package for Ukraine, funded by frozen Russian assets. Additionally, she addresses the U.S.-China relationship and the critical role of the U.S. dollar as a global currency, emphasizing strategies for maintaining economic stability.

9 snips
Dec 11, 2024 • 9min
Goldman Sachs Asset Management Head Marc Nachmann Talks Third-Party Fundraising
Goldman Sachs Asset Management Head Marc Nachmann discusses the move towards third-party fundraising and the future of M&A with Bloomberg's Sonali Basak at the Goldman Sachs Financial Services Conference.See omnystudio.com/listener for privacy information.

7 snips
Dec 11, 2024 • 9min
Ares Management CEO Mike Arougheti Talks Record Breaking Fundraising Year
Mike Arougheti, CEO of Ares Management, shares insights into his firm’s record-breaking fundraising year and innovative capital-raising strategies. He discusses emerging investment opportunities despite high interest rates, showcasing the link between available capital and increased M&A activity expected by 2025. Arougheti highlights the resilience of private credit and real estate markets, while emphasizing the importance of adapting strategies for distressed assets and diversified portfolios in a shifting economic landscape.

8 snips
Dec 11, 2024 • 10min
Goldman Sachs CFO Denis Coleman Talks Trump's FTC Nomination
Denis Coleman, CFO of Goldman Sachs, shares insights on the future of mega merger deals and the current M&A climate. He predicts a revival in large-scale transactions exceeding $50 billion by 2025, fueled by strong client interest. Coleman discusses the impressive 52% boost in Goldman Sachs' stock value and how regulatory shifts could enhance business confidence. He highlights the challenges posed by potential interest rate hikes and emphasizes the importance of talent acquisition amid economic uncertainty, setting the stage for future growth.

6 snips
Dec 10, 2024 • 44min
Eli Lilly CEO Dave Ricks Talks Weight Loss Drugs Success
In this discussion, Dave Ricks, CEO of Eli Lilly, shares insights on the company's groundbreaking weight-loss drugs, like Zepbound and terzepatide. He elaborates on their potential in treating addictive behaviors and combating the rising global obesity crisis. Ricks highlights the need for accessible treatments and the complexities of drug manufacturing. He also reflects on his career journey and the transformative impact these medications can have on patients' lives, emphasizing the importance of sustainable health changes.


